CombiMatrix Molecular Diagnostics Receives CLIA Certification
Friday March 31, 6:01 am ET
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--March 31, 2006--Acacia Research Corporation (NASDAQ:CBMX - News; NASDAQ:ACTG - News) announced today its CombiMatrix group's wholly-owned subsidiary, CombiMatrix Molecular Diagnostics (CMDX), has received certification to operate as a clinical laboratory in accordance with the federal government's Clinical Laboratory Improvement Act (CLIA), a regulatory program that monitors the quality of laboratory testing. According to CLIA, any laboratory in the U.S. that conducts testing on human specimens for purposes other than research must be certified.
ADVERTISEMENT
"This is an important milestone for our company," said Matt Watson, CEO of CMDX. "Since opening our doors in May of 2005 we have been working diligently to establish a program of processes and procedures that would meet CLIA's strict quality control and quality assurance standards. Now that we have met those standards we are cleared to begin offering high quality clinical testing services at our state-of-the-art laboratory in Irvine, California."
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group.
The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.
The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 42 patent portfolios, which include over 160 U.S. patents, and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency, credit card fraud protection, database management, data encryption & product activation, digital media transmission (DMT®), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, hearing aid ECS, image resolution enhancement, interactive data sharing, interactive television, interstitial Internet advertising, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging and spreadsheet automation.
Acacia Research-Acacia Technologies (NASDAQ:ACTG - News) and Acacia Research-CombiMatrix (NASDAQ:CBMX - News) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.
AI
